In preliminary analysis using a small cohort of cases with available post-mortem CSF (Control = 4, CTE = 7, AD = 4), there was a trend towards increased CCL11 levels in CTE, but not AD, compared to controls (Fig 3A). The gene discussed is CCL11; the disease is Alzheimer disease.